Filing Details
- Accession Number:
- 0001209191-23-012015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-22 20:25:50
- Reporting Period:
- 2023-02-22
- Accepted Time:
- 2023-02-22 20:25:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1672619 | Imara Inc. | IMRA | Pharmaceutical Preparations (2834) | 811523849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1805097 | D. Rahul Ballal | C/O Imara Inc. 116 Huntington Avenue, 6Th Floor Boston MA 02116 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-22 | 32,861 | $4.66 | 87,835 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Billionaire Hedge Funds
